Thymomas: Review of Current Clinical Practice

Annals of Thoracic Surgery

Volumn 87, Issue 6, 2009, Pages 1973-1980

  Tomaszek, Sandra ^a   Wigle, Dennis A ^a   Keshavjee, Shaf ^b   Fischer, Stefan ^c  

^a MAYO CLINIC   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; THYMOMA; TUMOR CLASSIFICATION;

HUMANS; THYMOMA; THYMUS NEOPLASMS;

EID: 65649147862     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.12.095     Document Type: Review

References (78)

1. Cowen D., Richaud P., Mornex F., et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 34 (1995) 9-16
2. Hon C., Chui W.H., Cheng L.C., Shek T.W., Jones B.M., and Au W.Y. Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells. J Clin Oncol 24 (2006) 2960-2961
3. Miyakis S., Pefanis A., Passam F.H., Christodulakis G.R., Roussou P.A., and Mountokalakis T.D. Thymoma with immunodeficiency (Good's syndrome): review of the literature apropos three cases. Scand J Infect Dis 38 (2006) 314-319
4. Murakawa T., Nakajima J., Sato H., Tanaka M., Takamoto S., and Fukayama M. Thymoma associated with pure red-cell aplasia: clinical features and prognosis. Asian Cardiovasc Thorac Ann 10 (2002) 150-154
5. Skeie G.O., Apostolski S., Evoli A., et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 13 (2006) 691-699
6. Engels E.A., and Pfeiffer R.M. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105 (2003) 546-551
7. Chen G., Marx A., Wen-Hu C., et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
8. Harris N.L., and Müller-Hermelink H.K. Thymoma classification: a siren's song of simplicity. Am J Clin Pathol 112 (1999) 299-303
9. Kornstein M.J. Thymoma classification: my opinion. Am J Clin Pathol 112 (1999) 304-307
10. Suster S., and Moran C.A. Thymoma classification. The ride of the valkyries?. Am J Clin Pathol 112 (1999) 308-310
11. Kuo T.T. Classification of thymic epithelial neoplasms: a controversial issue coming to an end?. J Cell Mol Med 5 (2001) 442-448
12. Bernatz P.E., Harrison E.G., and Clagett O.T. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 42 (1961) 424-444
13. Rosai J., and Levine G.D. Tumors of the thymus. Atlas of Tumor Pathology 2nd series, Fasc 13 (1976), Armed Forces Institute of Pathology, Washington, DC
14. Marino M., and Müller-Hermelink H.K. Thymoma and thymic carcinoma: Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407 (1985) 119-149
15. Müller-Hermelink H.K., Ströbel P., Zettl A., et al. Combined thymic epithelial tumours. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (WHO classification of tumours series) (2004), IARC Press, Lyon, France 196-198
16. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus and heart (WHO classification of tumours series) (2004), IARC Press, Lyon, France 152-171
17. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
18. Gamondès J.P., Balawi A., Greenland T., et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 5 (1991) 124-131
19. Yamakawa Y., Masaoka A., Hashimoto T., et al. A tentative tumor-node-metastasis classification of thymoma. Cancer 68 (1991) 1984-1987
20. Tsuchiya R., Koga K., Matsuno Y., Mukai K., and Shimosato Y. Thymic carcinoma: proposal for pathological TNM and staging. Pathol Int 44 (1994) 505-512
21. Bedini A.V., Andreani S.M., Tavecchio L., et al. Proposal of a novel system for the staging of thymic epithelial tumors. Ann Thorac Surg 80 (2005) 1994-2000
22. Evoli A., Minisci C., Di Schino C., et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 59 (2002) 1844-1850
23. Kim D.J., Yang W.I., Choi S.S., Kim K.D., and Chung K.Y. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest 127 (2005) 755-761
24. Ogawa K., Uno T., Toita T., et al. Postoperative radiotherapy for patients with completely resected thymoma. A multi-institutional, retrospective review of 103 patients. Cancer 94 (2002) 1405-1413
25. Okumura M., Ohta M., Tateyama H., et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
26. Rea F., Marulli G., Girardi R., et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 26 (2004) 412-418
27. Rena O., Papalia E., Maggi G., et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 50 (2005) 59-66
28. Ströbel P., Bauer A., Puppe B., et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22 (2004) 1501-1509
29. Wright C.D., Wain J.C., Wong D.R., et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
30. Nakagawa K., Asamura H., Matsuno Y., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
31. Yang W.T., Lei K.I., and Metreweli C. Plain radiography and computed tomography of invasive thymomas: clinico-radiologic-pathologic correlation. Australas Radiol 41 (1997) 118-124
32. Maher M.M., and Shepard J.A. Imaging of thymoma. Semin Thorac Cardiovasc Surg 17 (2005) 12-19
33. Tomiyama N., Honda O., Tsubamoto M., et al. Anterior mediastinal tumors: Diagnostic accuracy of CT and MRI. Eur J Radiol 69 (2009) 280-288
34. Han J., Lee K.S., Yi C.A., et al. Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol 4 (2003) 46-53
35. Inoue A., Tomiyama N., Fujimoto K., et al. MR imaging of thymic epithelial tumors: correlation with World Health Organization classification. Radiat Med 24 (2006) 171-181
36. Endo M., Nakagawa K., Ohde Y., et al. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 61 (2008) 350-355
37. Sung Y.M., Lee K.S., Kim B.T., Choi J.Y., Shim Y.M., and Yi C.A. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 47 (2006) 1628-1634
38. Higuchi T., Taki J., Kinuya S., et al. Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy. Radiology 221 (2001) 201-206
39. Ali S.Z., and Erozan Y.S. Thymoma. Cytopathologic features and differential diagnosis on fine needle aspiration. Acta Cytol 42 (1998) 845-854
40. Chhieng D.C., Rose D., Ludwig M.E., and Zakowski M.F. Cytology of thymomas: emphasis on morphology and correlation with histologic subtypes. Cancer 90 (2000) 24-32
41. Shin H.J., and Katz R.L. Thymic neoplasia as represented by fine needle aspiration biopsy of anterior mediastinal masses. A practical approach to the differential diagnosis. Acta Cytol 42 (1998) 855-864
42. Annessi V., Paci M., De Franco S., et al. Diagnosis of anterior mediastinal masses with ultrasonically guided core needle biopsy. Chir Ital 55 (2003) 379-384
43. Kramer H., Sanders J., Post W.J., Groen H.J., and Suurmeijer A.J. Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration. Cancer 108 (2006) 206-211
44. Larghi A., Noffsinger A., Dye C.E., Hart J., and Waxman I. EUS-guided fine needle tissue acquisition by using high negative pressure suction for the evaluation of solid masses: a pilot study. Gastrointest Endosc 62 (2005) 768-774
45. Assaad M.W., Pantanowitz L., and Otis C.N. Diagnostic accuracy of image-guided percutaneous fine needle aspiration biopsy of the mediastinum. Diagn Cytopathol 35 (2007) 705-709
46. Haniuda M., Kondo R., Numanami H., Makiuchi A., Machida E., and Amano J. Recurrence of thymoma: clinicopathological features, re-operation, and outcome. J Surg Oncol 78 (2001) 183-188
47. Regnard J.F., Magdeleinat P., Dromer C., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
48. Wright C.D., Choi N.C., Wain J.C., Mathisen D.J., Lynch T.J., and Fidias P. Induction chemotherapy followed by resection for locally advanced Masaoka Stage III and IVa thymic tumors. Ann Thorac Surg 85 (2008) 385-389
49. Zhu G., He S., Fu X., Jiang G., and Liu T. Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 60 (2004) 1113-1119
50. Blalock A., McGehee A.H., and Ford F.R. The treatment of myasthenia gravis by removal of the thymus. JAMA 18 (1941) 1529-1533
51. Aubert A., Chaffanjon P., and Brichon P.Y. Video-assisted extended thymectomy in patients with thymoma by lifting the sternum: is it safe?. Ann Thorac Surg 77 (2004) 1878
52. Ferguson M.K. Transcervical thymectomy. Semin Thorac Cardiovasc Surg 11 (1999) 59-64
53. Cheng Y.J., Kao E.L., and Chou S.H. Videothoracoscopic resection of stage II thymoma: prospective comparison of the results between thoracoscopy and open methods. Chest 128 (2005) 3010-3012
54. Iablonski P.K., Pishchik V.G., and Nuraliev S.M. Comparative assessment of the effectiveness of traditional and videothoracoscopic thymectomies in complex treatment of myasthenic thymomas. Vestn Khir Im I I Grek 164 (2005) 38-42
55. Kondo K., and Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 (2003) 878-884
56. Singhal S., Shrager J.B., Rosenthal D.I., LiVolsi V.A., and Kaiser L.R. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1641
57. Mangi A.A., Wain J.C., Donahue D.M., Grillo H.C., Mathisen D.J., and Wright C.D. Adjuvant radiation of stage III thymoma: is it necessary?. Ann Thorac Surg 79 (2005) 1834-1839
58. Cesaretti J.A. Adjuvant radiation with modern techniques is the standard of care for stage III thymoma. Ann Thorac Surg 81 (2006) 1180-1181
59. Sugie C., Shibamoto Y., Ikeya-Hashizume C., et al. Invasive thymoma: postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination. J Thorac Oncol 3 (2008) 75-81
60. Loehrer Sr. P.J., Jiroutek M., Aisner S., et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91 (2001) 2010-2015
61. Berruti A., Borasio P., Gerbino A., et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 81 (1999) 841-845
62. Giaccone G., Ardizzoni A., Kirkpatrick A., Clerico M., Sahmoud T., and van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14 (1996) 814-820
63. Bretti S., Berruti A., Loddo C., et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer 44 (2004) 69-77
64. Shin D.M., Walsh G.L., Komaki R., et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129 (1998) 100-104
65. Jacot W., Quantin X., Valette S., Khial F., and Pujol J.L. Multimodality treatment program in invasive thymic epithelial tumor. Am J Clin Oncol 28 (2005) 5-7
66. Venuta F., Rendina E.A., Pescarmona E.O., et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 64 (1997) 1585-1591
67. Lucchi M., Ambrogi M.C., Duranti L., et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 79 (2005) 1840-1844
68. Kim E.S., Putnam J.B., Komaki R., et al. Phase II study of multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44 (2004) 369-379
69. Huang J., Riely G.J., Rosenzweig K.E., and Rusch V.W. Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy?. Ann Thorac Surg 85 (2008) 365-367
70. Huang J., Rizk N.P., Travis W.D., et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 134 (2007) 1477-1483
71. Kondo K., and Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg 79 (2005) 219-224
72. In: Grehl H., and Reinhardt F. (Eds). Checkliste Neurologie. 3rd Ed. (2005), Georg Thieme Verlag, Stuttgart, Germany 670-678
73. Bartoccioni E., Scuderi F., Minicuci G.M., Marino M., Ciaraffa F., and Evoli A. Anti-MuSk antibodies: correlation with myasthenia gravis severity. Neurology 67 (2006) 505-507
74. Morgan B.P., Chamberlain-Banoub J., Neal J.W., Song W., Mizuno M., and Harris C.L. The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice. Clin Exp Immunol 146 (2006) 294-302
75. Romi F., Bø L., Skeie G.O., Myking A., Aarli J.A., and Gilhus N.E. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128 (2002) 82-89
76. Li Y.F., Li Y.H., and Cui L.Y. Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28 (2006) 517-519
77. Sasaki H., Ide N., Fukai I., Kiriyama M., Yamakawa Y., and Fujii Y. Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer 101 (2002) 342-347
78. Lee G.Y., Yang W.I., Jeung H.C., et al. Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics 8 (2007) 305